biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > how do the few longs feel about jd leaving you?

<< Previous

Bullboard Posts

Next >>

Comment by beenthereon Nov 11, 2022 7:53pm

138 Views

Post# 35092994

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:how do the few longs feel about jd leaving you?

JD: " Maybe I'll write a book about Bioasis after it is fully resolved."

Why would anyone want to write a book about a bankrupt stock!
AND who would want to read it?

JD you are just getting worse and worse! Give it up! Walk off into the sunset! I'm embarrassed for you!

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages